# FASEB's "The NAD+ Metabolism and Signaling Conference"

> **NIH NIH R13** · FEDERATION OF AMER SOC FOR EXPER BIOLOGY · 2021 · $44,200

## Abstract

Summary
 This proposal requests partial support for the FASEB Research Conference on “NAD+ Metabolism and
Signaling” to be held June 13-18, 2021 at the Westin Snowmass Hotel, Snowmass, CO. This conference, which
began in 2009 and has been attended biennially by researchers from across the world, is critical to the mission
of the NIA because NAD+-dependent processes mediate key aspects of healthy aging and metabolic disorders.
Although there are specialized conferences that focus on Sirtuins, poly(ADP-ribose) polymerases (PARPs),
calcium signaling, and drugs and nutritional interventions that interface with the fundamental and translational
science of NAD+ (e.g., aging, metabolism, cancer), this conference is the only one that cuts across all of these
areas. The strength and innovation of this meeting is that it provides a unique venue for cross-disciplinary
interactions among NAD+ biologists from diverse areas, who use a wide variety of approaches and model
systems. This conference will (1) bring together leading scientists working on NAD+ metabolism and signaling,
(2) create networking and career opportunities for early-stage investigators, (3) train the next generation of
scientists, and (4) promote the improvement of human health as it pertains to NAD+ metabolism and signaling.
 The major goals of this conference are to: (1) share the most current information on NAD+ metabolism
and signaling, (2) foster new interactions among scientists who do not normally interact to promote
interdisciplinary interactions and collaborations, (3) provide career and training opportunities for early-stage
investigators and trainees through interactions with leaders in the field, and (4) facilitate translational research
leading to improvements in healthy aging and other aspects of human health. We expect that new insights from
this meeting will advance the entire field and lead to a greater evidence-based understanding of NAD+
metabolism in healthy people, as well as in individuals affected by diseases of aging. The objective of this
proposal is to obtain funds to support conference fees for outstanding junior investigators, as well as those who
are underrepresented in science. To meet these goals and objective, we propose three specific aims: (1)
finalize the scientific program by selecting individuals from the submitted abstracts to present short talks that will
complement other talks presented at the meeting; (2) identify early-stage scientists and trainees who will receive
financial support, and (3) provide administrative support to distribute the funds from this R13 mechanism.
 The organizing committee comprises four members (Drs. Kraus, Mostoslavsky, Gorbunova, and Guse),
who were nominated by the 2019 FASEB NAD+ Metabolism and Signaling conference organizers and voted on
by the participants at that meeting. Each member is an expert in one or more of the topics that will be covered
during the course of the meeting. The organizers have relied on their diver...

## Key facts

- **NIH application ID:** 10143710
- **Project number:** 1R13AG071153-01
- **Recipient organization:** FEDERATION OF AMER SOC FOR EXPER BIOLOGY
- **Principal Investigator:** WILLIAM Lee KRAUS
- **Activity code:** R13 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $44,200
- **Award type:** 1
- **Project period:** 2021-03-01 → 2023-02-28

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10143710

## Citation

> US National Institutes of Health, RePORTER application 10143710, FASEB's "The NAD+ Metabolism and Signaling Conference" (1R13AG071153-01). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10143710. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*